“As of January 2018 Addgene has distributed more than 100,000 CRISPR plasmids to 3,400 laboratories worldwide. More than 6,300 CRISPR-related plasmids have been developed by over 330 academic labs and deposited into Addgene’s collection. Geographically, new CRISPR plasmids have been developed and deposited to Addgene’s collection from the Americas (led by the United States), Europe (led by Denmark), Asia (led by China), and Oceania (led by Australia), and shipped to some 75 countries.” [Reference: Enabling the Rise of a CRISPR World, Caroline M. LaManna and Rodolphe Barrangou, The CRISPR Journal, Vol. 1, n. 3, 2018]
Spanish microbiologist Francisco Mojica is credited with coining the name CRISPR, but crisper definitions are possible, as @KevinADavies tweeted some time ago. What does CRISPR “actually” stand for?
60 minutes is considered “the most successful news magazine in TV history”. Don’t miss this CRISPR episode, featuring Feng Zhang, Eric Lander, Kang Zhang and Shoukhrat Mitalipov.
Let me come out. I enjoyed it, and I’m not much worried about so many people learning the word CRISPR from a popcorn movie. A little fun never killed any technology, and Rampage, by Brad Peyton, is less dumb than it may seem. Continue reading
It’s 2045; the Gene Revolution is changing humanity. The US has lost its technological crown, and the biotech capital of the world is now Singapore. In Change Agent, the techno-thriller by Daniel Suarez, the night is lit by bioluminescent trees, children play with neotenic pets, drug addicts enjoy custom highs, specialized for their individual DNA. International law prohibits human edits beyond those designed to correct a short UN-approved list of genetic diseases. But a few years after ratification, the UN Treaty on Genetic Modification is already a dead letter. Continue reading
Up and down, following the excitement for the latest scientific exploit or frustration for disappointing results. CRISPR is young but already knows how volatile is the market. “Preprint wipes millions off CRISPR companies’ stocks,” cries the March issue of Nature Biotechnology. Continue reading